The Impact of Coronavirus Disease 2019 on Patients Living with Rheumatic Diseases.

Publication date: Feb 01, 2025

The coronavirus disease 2019 (COVID-19) pandemic severely impacted patients with rheumatic musculoskeletal diseases (RMDs), worsening health disparities, disrupting care, and affecting mental health. RMD patients, especially from marginalized communities, faced heightened COVID-19 susceptibility and severe outcomes. Telemedicine emerged as an important tool for maintaining access to care during the early pandemic period but highlighted disparities in access to the necessary technologies. Despite vaccinations providing protection in the general population, they were not effective in some patients with RMDs, especially those using B cell depletion therapies. Tailored management strategies and ongoing support, including mental health resources, are essential as COVID-19 persists.

Concepts Keywords
Coronavirus COVID-19
Covid COVID-19 pandemic
Therapy Health Services Accessibility
Vaccinations Healthcare Disparities
Worsening Humans
Immunosupression
Mental health
Rheumatic disease
Rheumatic Diseases
SARS-CoV-2
Telemedicine
Telemedicine

Semantics

Type Source Name
disease MESH Coronavirus Disease 2019
disease MESH Rheumatic Diseases
disease MESH musculoskeletal diseases
disease MESH health disparities
disease IDO susceptibility
disease MESH access to care
disease IDO cell

Original Article

(Visited 1 times, 1 visits today)